ECBK vs CARE vs KO

For growth investors, ECB Bancorp, Inc.

(ECBK) is the stronger pick with 16. 5% revenue growth year-over-year, versus 1. 9% for The Coca-Cola Company (KO). ECB Bancorp, Inc. (ECBK) offers the better valuation at 21. 6x trailing P/E, making it the more compelling value choice. Analysts rate The Coca-Cola Company (KO) a "Buy" — based on 48 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, ECB Bancorp, Inc.

(ECBK) is the cheapest at 21. 6x versus The Coca-Cola Company at 26. 1x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 5. 7x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Carter Bankshares, Inc.

(CARE) delivered a total return of +139. 8%, compared to +44. 1% for ECB Bancorp, Inc. (ECBK). Over 10 years, the gap is even starker: CARE returned +150. 2% versus ECBK's +44. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.

24β versus Carter Bankshares, Inc. 's 0. 50β — meaning CARE is approximately -310% more volatile than KO relative to the S&P 500. On balance sheet safety, Carter Bankshares, Inc. (CARE) carries a lower debt/equity ratio of 43% versus 166% for ECB Bancorp, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), ECB Bancorp, Inc.

(ECBK) is pulling ahead at 16. 5% versus 1. 9% for The Coca-Cola Company (KO). On earnings-per-share growth, the picture is similar: ECB Bancorp, Inc. grew EPS 95. 8% year-over-year, compared to 23. 6% for The Coca-Cola Company. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

The Coca-Cola Company (KO) is the more profitable company, earning 27.

3% net margin versus 9. 8% for ECB Bancorp, Inc. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus 13. 1% for ECBK. At the gross margin level — before operating expenses — CARE leads at 61. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Carter Bankshares, Inc.

(CARE) trades at 5. 7x forward P/E versus 24. 3x for The Coca-Cola Company — 18. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KO: 8. 5% to $86. 13.

In this comparison, KO (2.

6% yield) pays a dividend. ECBK, CARE do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

24), 2. 6% yield, +115. 0% 10Y return). Both have compounded well over 10 years (KO: +115. 0%, ECBK: +44. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ECBK (Financial Services) and CARE (Financial Services) and KO (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ECBK is a small-cap high-growth stock; CARE is a small-cap quality compounder stock; KO is a large-cap quality compounder stock. KO pays a dividend while ECBK, CARE do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.